Colloidal Silver: The Supplement That Turns You Blue

Colloidal silver is a suspension of silver particles in water. It has been sold since the early 1900s as an antibiotic, antiviral, and immune booster. It does not work for any of these uses in people. It does cause a permanent, irreversible condition called argyria that turns the skin a blue-grey color. And it is still on store shelves despite a 1999 FDA final rule that found no over-the-counter colloidal silver product is generally recognized as safe or effective for treating any disease.

The Mechanism Fallacy

Silver does kill germs in the right setting. Silver-coated catheters, silver sulfadiazine creams for burns, and silver-containing wound dressings are used in hospitals for surface infection control. Swallowing colloidal silver is a different story. The amount that reaches the bloodstream is far below what would kill bacteria or viruses inside the body. The silver is absorbed, gets stored in skin and other tissues, and does no antimicrobial work where you need it.

Argyria: The Permanent Blue Consequence

Argyria happens when silver builds up in the skin. Sunlight then turns those silver deposits into silver sulfide, which is blue-grey. Discoloration usually starts in sun-exposed areas first — face, hands, arms, and the gum line — and gets darker with more use. It does not fade when the supplement is stopped. Many cases appear in the peer-reviewed literature, including patients with skin and nail discoloration after long-term self-treatment (Kim 2009; Kwon 2009; Slater 2022; Simon 2020), a child with cystic fibrosis who used colloidal silver for mucus clearance (Baker 2007), and a 70-year-old man who developed seizures, not just a color change, after self-medicating (Hu 2023). Dermatologists keep seeing new cases — almost all from supplement use, not workplace exposure.

The Body's "Safe" Limit Is Tiny

The U.S. EPA's oral reference dose for silver is 5 micrograms per kilogram per day — about 350 micrograms per day for a 70-kg adult, set to avoid argyria. A typical "immune-support" teaspoon of a 10 ppm colloidal silver product delivers roughly 50 micrograms per dose; many products on the market contain hundreds to thousands of micrograms per recommended serving, putting daily users above the EPA limit within one dose. A 2017 systematic review in Environmental Health (Fewtrell 2017) also flagged unresolved genotoxicity concerns from particulate silver in mammalian studies, on top of the well-established argyria risk.

Regulatory History and COVID Claims

In 1999 the FDA issued a final rule (21 CFR 310.548) stating that over-the-counter drug products containing colloidal silver or silver salts are not generally recognized as safe or effective for any disease. Despite that, colloidal silver still sells as a "dietary supplement" using vague structure-function claims (such as "supports immune health") that side-step the disease-treatment language the FDA banned. During the COVID-19 pandemic, the FDA and FTC sent joint warning letters to companies marketing colloidal silver as a COVID treatment — a reminder that these claims simply migrate to whichever health worry is in the news.